Induction of vascular endothelial growth factor (VEGF) by hyperthermia and/or an angiogenesis inhibitor
- 1 January 1999
- journal article
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 15 (4) , 267-278
- https://doi.org/10.1080/026567399285648
Abstract
Intratumoral localization of vascular endothelial growth factor (VEGF) following administration of hyperthermia (HT) and/or anti-angiogenic drugs (TNP-470) was evaluated using SCC VII tumours in C3H/He mice. Hyperthermia at 44.0 degrees C for 30 min was given with a water bath on day 0. TNP-470 (100 mg/kg) was administered alone or after HT on day 0 and day 3. Histological changes on day 4 were evaluated by haematoxylin-eosin (HE) staining and immunohistochemical staining for VEGF. The percentage of the necrotic area relative to the entire tumour area (the % necrotic area) was measured on HE stains. The average % necrotic area of the untreated SCC VII tumours was 7%, while those of tumours treated with TNP-470 alone and HT alone were 27 or 65%, respectively. When HT and TNP-470 were combined, the % necrotic area was 82%, which was significantly higher than that caused by HT alone (p < 0.05). Immunohistochemical staining for VEGF in untreated SCC VII tumours was weak, although strong staining for VEGF was noted in untreated EMT-6 tumours of BALB/c mice, which have spontaneous central necrosis. After administration of HT and/or TNP-470, layer-shaped staining by VEGF was observed in the residual SCC VII tumour cells adjacent to the necrotic area. In conclusion, the expression of VEGF increased in response to administration of HT and/or TNP-470. Hypoxia caused by heat-induced vascular damage may be attributable to increased expression of VEGF in SCC VII tumours.Keywords
This publication has 13 references indexed in Scilit:
- An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1997
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Comparison of in vivo Efficacy of Hypoxic Cytotoxin Tirapazamine and Hypoxic Cell Radiosensitizer KU‐2285 in Combination with Single and Fractionated IrradiationJapanese Journal of Cancer Research, 1996
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Analysis of experimental antiangiogenic therapyJournal of Pediatric Surgery, 1993
- Differential thermal sensitivity of tumour and normal tissue microvascular response during hyperthermiaInternational Journal of Hyperthermia, 1992
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- Microangiographic and histologic analysis of the effects of hyperthermia on murine tumor vasculatureInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Pathophysiology of Tumors in HyperthermiaPublished by Springer Nature ,1988
- Tumour microcirculation as a target for hyperthermiaInternational Journal of Hyperthermia, 1986